Login / Signup

High Prevalence of Strongyloidiasis in Spain: A Hospital-Based Study.

Ana Requena-MéndezJoaquin Salas-CoronasFernando SalvadorJoan Gomez-JunyentJudith Villar-GarciaMiguel SantinCarme MuñozAna González-CordónMaria Teresa Cabezas FernándezElena SulleiroMaria Del Mar ArenasDolors SomozaJose Vazquez-VillegasBegoña TreviñoEsperanza RodríguezMaria Eugenia VallsJaume LLaberia-MarcualCarme SubiràJose Muñoz
Published in: Pathogens (Basel, Switzerland) (2020)
Introduction: Strongyloidiasis is a prevailing helminth infection ubiquitous in tropical and subtropical areas, however, seroprevalence data are scarce in migrant populations, particularly for those coming for Asia. Methods: This study aims at evaluating the prevalence of S. stercoralis at the hospital level in migrant populations or long term travellers being attended in out-patient and in-patient units as part of a systematic screening implemented in six Spanish hospitals. A cross-sectional study was conducted and systematic screening for S. stercoralis infection using serological tests was offered to all eligible participants. Results: The overall seroprevalence of S. stercoralis was 9.04% (95%CI 7.76-10.31). The seroprevalence of people with a risk of infection acquired in Africa and Latin America was 9.35% (95%CI 7.01-11.69), 9.22% (7.5-10.93), respectively. The number of individuals coming from Asian countries was significantly smaller and the overall prevalence in these countries was 2.9% (95%CI -0.3-6.2). The seroprevalence in units attending potentially immunosuppressed patients was significantly lower (5.64%) compared with other units of the hospital (10.20%) or Tropical diseases units (13.33%) (p < 0.001). Conclusions: We report a hospital-based strongyloidiasis seroprevalence of almost 10% in a mobile population coming from endemic areas suggesting the need of implementing strongyloidiasis screening in hospitalized patients coming from endemic areas, particularly if they are at risk of immunosuppression.
Keyphrases
  • healthcare
  • risk factors
  • case report
  • climate change
  • acute care
  • ejection fraction
  • adverse drug
  • newly diagnosed
  • electronic health record
  • machine learning
  • big data
  • patient reported outcomes